Vascular Regeneration Cell Therapy
Vascular Insufficiency (e.g., Critical Limb Ischemia)
Key Facts
About VascVersa
VascVersa is a private, pre-clinical stage biotech company pioneering cell therapies for vascular regeneration. Built on extensive academic research from Queen's University Belfast, the company is developing a platform to repair damaged blood vessels, targeting a significant unmet medical need in cardiovascular and ischemic diseases. While currently pre-revenue and with a pipeline in early development, VascVersa is actively engaging with the global cell and gene therapy community, as evidenced by its participation in key industry conferences like ISCT 2024. The company appears to be in a strategic build-out phase, refreshing its public-facing materials while advancing its scientific programs.
View full company profile